Abstract:Hepatitis B virus (HBV) infection is a global public health issue. We offer a comprehensive analysis of the dynamics of HBV, which can be successfully controlled with vaccine and treatment. Hepatitis B virus (HBV) causes a significantly more severe and protracted disease compared to hepatitis A. While it initially presents as an acute disease, in approximately 5 to 10% of cases, it can develop into a chronic disease that causes permanent damage to the liver. The hepatitis B virus can remain active outside the body for at least seven days. If the virus penetrates an individual's body without immunization, it may still result in infection. Upon exposure to HBV, the symptoms often last for a duration ranging from 10 days to 6 months. In this study, we developed a new model for Hepatitis B Virus (HBV) that includes asymptomatic carriers, vaccination, and treatment classes to gain a comprehensive knowledge of HBV dynamics. The basic reproduction number [Formula: see text] is calculated to identify future recurrence. The local and global stabilities of the proposed model are evaluated for values of [Formula: see text] that are both below and above 1. The Lyapunov function is employed to ensure the global stability of the HBV model. Further, the existence and uniqueness of the proposed model are demonstrated. To look at the solution of the proposed model graphically, we used a useful numerical strategy, such as the non-standard finite difference method, to obtain more thorough numerical findings for the parameters that have a significant impact on disease elimination. In addition, the study of treatment class in the population, we may assess the effectiveness of alternative medicines to treat infected populations can be determined. Numerical simulations and graphical representations are employed to illustrate the implications of our theoretical conclusions.

Delayed Hepatitis B Epidemic Model with Stochastic Analysis

A Model of HBV Infection with Intervention Strategies: Dynamics Analysis and Numerical Simulations

Stochastic Analysis and Control for a Delayed Hepatitis B Epidemic Model.

A novel stochastic Hepatitis B virus epidemic model with second-order multiplicative α-stable noise and real data

Mathematical analysis of a new nonlinear stochastic hepatitis B epidemic model with vaccination effect and a case study

Stochastic Dynamics of Hepatitis B Epidemics

Stationary Distribution Extinction and Optimal Control for the Stochastic Hepatitis B Epidemic Model with Partial Immunity

Ergodic Stationary Distribution of Age-Structured HBV Epidemic Model with Standard Incidence Rate

A stochastic hepatitis B model with media coverage and Lévy noise

ANALYSIS OF A STOCHASTIC HBV INFECTION MODEL WITH NONLINEAR INCIDENCE RATE

Stochastic optimal analysis for the hepatitis B epidemic model with Markovian switching

Stochastic modeling and computational simulations of HBV infection dynamics

Dynamics of a Stochastic HBV Infection Model with Drug Therapy and Immune Response

Dynamics of Hepatitis B Virus Transmission with a Lévy Process and Vaccination Effects

Dynamical analysis of a general delayed HBV infection model with capsids and adaptive immune response in presence of exposed infected hepatocytes

Understanding the dynamics of hepatitis B transmission: A stochastic model with vaccination and Ornstein-Uhlenbeck process

Global dynamics and computational modeling for analyzing and controlling Hepatitis B: A novel epidemic approach

Dynamical Behaviour of an Anti-Hbv Infection Therapy Model with Time-Delayed Immune Response

Mathematical Model and Analysis of Transmission Dynamics of Hepatitis B Virus

Analysis Of An Hbv Model With Time Delay

Dynamics of a Stochastic HBV Infection Model with General Incidence Rate, Cell-to-cell Transmission, Immune Response and Ornstein–Uhlenbeck Process